Peter Blume-jensen
CEO, President at Acrivon Therapeutics, Inc. (ACRV)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-15.7%
vs. S&P 500-17.4%
Beat the market0%
Paper profit on buys+$11K
Total bought / sold$82K / $31K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 27SEC | ACRVAcrivon Therapeutics, Inc. | Sell | 14,0362,230,052 held (−1%) | $2.21 | $31K | -13.6% |
| Jan 16SEC | ACRVAcrivon Therapeutics, Inc. | Buy | 49,0002,095,771 held (+2%) | $1.68 | $82K | +13.7% |
- Buy
CEO, President Peter Blume-jensen bought $82K of ACRV at $1.68 — first open-market purchase in our records.